Moody Aldrich Partners’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-39,100
Closed -$4.28M 221
2023
Q4
$4.28M Buy
+39,100
New +$4.04M 0.77% 57
2023
Q3
Sell
-38,810
Closed -$5.27M 196
2023
Q2
$5.27M Sell
38,810
-30
-0.1% -$3.66K 1.02% 30
2023
Q1
$4.03M Sell
38,840
-13,045
-25% -$1.26M 0.81% 49
2022
Q4
$4.6M Sell
51,885
-20,115
-28% -$1.67M 0.93% 43
2022
Q3
$5.77M Buy
72,000
+1,599
+2% +$151K 1.19% 25
2022
Q2
$6.74M Buy
70,401
+1,171
+2% +$141K 1.32% 22
2022
Q1
$10.3M Buy
69,230
+13,567
+24% +$1.89M 1.45% 22
2021
Q4
$7.89M Buy
55,663
+2,406
+5% +$341K 1.1% 35
2021
Q3
$6.97M Buy
53,257
+7,590
+17% +$993K 0.88% 53
2021
Q2
$6.28M Sell
45,667
-14,326
-24% -$1.96M 0.88% 52
2021
Q1
$7.83M Buy
59,993
+988
+2% +$119K 1.13% 29
2020
Q4
$6.61M Buy
59,005
+19,114
+48% +$1.81M 1.07% 33
2020
Q3
$3.14M Buy
39,891
+12,092
+43% +$986K 0.66% 71
2020
Q2
$2M Buy
27,799
+4,079
+17% +$284K 0.43% 86
2020
Q1
$1.36M Sell
23,720
-50
-0.2% -$4.61K 0.41% 85
2019
Q4
$2.66M Buy
23,770
+206
+0.9% +$22K 0.55% 75
2019
Q3
$2.27M Sell
23,564
-270
-1% -$25.3K 0.6% 65
2019
Q2
$2.04M Sell
23,834
-38,745
-62% -$3.18M 0.52% 73
2019
Q1
$5.21M Buy
62,579
+36,326
+138% +$2.64M 1.46% 20
2018
Q4
$1.69M Buy
26,253
+1,866
+8% +$128K 0.55% 71
2018
Q3
$1.93M Buy
24,387
+3,941
+19% +$305K 0.56% 78
2018
Q2
$1.5M Buy
+20,446
New +$1.39M 0.53% 77

Other funds holding CNMD

Moody Aldrich Partners's CNMD Position: Q1 2024 in Review

Moody Aldrich Partners sold out of CONMED (CNMD) in Q1 2024, closing a stake of 39,100 shares — an estimated $4.28M sold.

Moody Aldrich Partners first reported a position in CNMD in Q2 2018 and held it in 22 quarters. The position peaked at $10.3M in Q1 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Moody Aldrich Partners reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 39,100 CONMED shares in Q1 2024, an estimated $4.28M.
  • Moody Aldrich Partners first reported a position in CONMED in Q2 2018 and held it in 22 quarters.
  • Moody Aldrich Partners's CONMED position peaked at $10.3M in Q1 2022.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Moody Aldrich Partners's 13F filing for Q1 2024, filed 30 Apr 2024.